Validity and reliability of the Greek version of the neurogenic bladder symptom score (NBSS) questionnaire in a sample of Greek patients with multiple sclerosis.
Greek validation
NBSS questionnaire
Quality of life
Urinary bladder
Urinary incontinence
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
08
07
2020
accepted:
19
09
2020
pubmed:
29
9
2020
medline:
12
1
2022
entrez:
28
9
2020
Statut:
ppublish
Résumé
There is no data regarding validity and reliability of the Greek version of Neurogenic Bladder Symptom Score (NBSS) questionnaire. In this study we investigated these parameters using a sample of Greek patients with multiple sclerosis (MS). Patients with different types and severity of multiple sclerosis were recruited from a single center in Greece prospectively. All patients completed the MusiQoL and NBSS questionnaires at baseline and 20 days later, without receiving any new treatment. Construct validity, internal consistency and test-retest reliability were tested. Internal consistency was investigated using Cronbach's alpha coefficient, while test-retest reliability using Intraclass Correlation Coefficient (ICC). Construct validity was assessed by comparing NBSS quality of life question 24 with MusiQoL questionnaire. A total of 91 patients were evaluated. The dimensions of NBSS exhibited high internal consistency, both for overall questionnaire score (Cronbach's alpha coefficient of 0.91) and for every subdomain separately (Cronbach's alpha coefficient of 0.95 for incontinence, 0.88 for storage symptoms and 0.74 for consequences). Test-retest reliability was satisfactory both for overall score [ICC of 0.85, (0.35-0.94), p < 0.001] and for every subdomain separately (ICC of 0.90 for incontinence, 0.83 for storage symptoms and 0.90 for consequences). Pearson's correlation coefficient of question number 24 of the NBSS questionnaire regarding quality of life with the MusiQoL questionnaire revealed a moderate correlation [r = 0.64, (0.48-0.80), p < 0.0001]. The Greek version of NBSS appears to be a valid and reliable instrument for assessing neurogenic bladder symptoms in Greek population suffering from multiple sclerosis.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
There is no data regarding validity and reliability of the Greek version of Neurogenic Bladder Symptom Score (NBSS) questionnaire. In this study we investigated these parameters using a sample of Greek patients with multiple sclerosis (MS).
MATERIALS AND METHODS
METHODS
Patients with different types and severity of multiple sclerosis were recruited from a single center in Greece prospectively. All patients completed the MusiQoL and NBSS questionnaires at baseline and 20 days later, without receiving any new treatment. Construct validity, internal consistency and test-retest reliability were tested. Internal consistency was investigated using Cronbach's alpha coefficient, while test-retest reliability using Intraclass Correlation Coefficient (ICC). Construct validity was assessed by comparing NBSS quality of life question 24 with MusiQoL questionnaire.
RESULTS
RESULTS
A total of 91 patients were evaluated. The dimensions of NBSS exhibited high internal consistency, both for overall questionnaire score (Cronbach's alpha coefficient of 0.91) and for every subdomain separately (Cronbach's alpha coefficient of 0.95 for incontinence, 0.88 for storage symptoms and 0.74 for consequences). Test-retest reliability was satisfactory both for overall score [ICC of 0.85, (0.35-0.94), p < 0.001] and for every subdomain separately (ICC of 0.90 for incontinence, 0.83 for storage symptoms and 0.90 for consequences). Pearson's correlation coefficient of question number 24 of the NBSS questionnaire regarding quality of life with the MusiQoL questionnaire revealed a moderate correlation [r = 0.64, (0.48-0.80), p < 0.0001].
CONCLUSIONS
CONCLUSIONS
The Greek version of NBSS appears to be a valid and reliable instrument for assessing neurogenic bladder symptoms in Greek population suffering from multiple sclerosis.
Identifiants
pubmed: 32986135
doi: 10.1007/s00345-020-03465-9
pii: 10.1007/s00345-020-03465-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2697-2702Informations de copyright
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Karimi M, Brazier J (2016) Health, health-related quality of life, and quality of life: what is the difference? Pharmaco Econ 34(7):645–649
doi: 10.1007/s40273-016-0389-9
Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N (2002) Patient-reported outcomes: the example of health-related quality of life—a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inform J 36(1):209–238
doi: 10.1177/009286150203600127
Hays RDRB (2010) Measurement and modeling of health-related quality of life. In: Killewo J, Heggenhougen HK, Quah SR (eds) Epidemiology and demography in public health. Academic Press, San Diego, pp 195–205
Ku JH (2006) The management of neurogenic bladder and quality of life in spinal cord injury. BJU Int 98(4):739–745
doi: 10.1111/j.1464-410X.2006.06395.x
Costa P, Perrouin-Verbe B, Colvez A et al (2001) Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Euro Urol. 39(1):107–113
doi: 10.1159/000052421
Narang GL, Pannell SC, Laviana AA et al (2017) Patient-reported outcome measures in urology. Curr Opin Urol 27(4):366–374
doi: 10.1097/MOU.0000000000000412
McKenna SP (2011) Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med. 9:86
doi: 10.1186/1741-7015-9-86
Welk B, Morrow SA, Madarasz W, Potter P, Sequeira K (2013) The conceptualization and development of a patient-reported neurogenic bladder symptom score. Res Rep Urol 5:129–137
pubmed: 24400244
pmcid: 3826942
Welk B, Morrow S, Madarasz W, Baverstock R, Macnab J, Sequeira K (2014) The validity and reliability of the neurogenic bladder symptom score. J Urol 192(2):452–457
doi: 10.1016/j.juro.2014.01.027
Laake P, Benestad H, Olsen BR (2007) Research methodology in the medical and biological sciences. Elsevier, Academic Press, Amsterdam
Welk B, Lenherr S, Elliott S et al (2018) The neurogenic bladder symptom score (NBSS): a secondary assessment of its validity, reliability among people with a spinal cord injury. Spinal cord 56(3):259–264
doi: 10.1038/s41393-017-0028-0
Pariser JJ, Welk B, Kennelly M, Elliott SP (2019) Reliability and validity of the neurogenic bladder symptom score in adults with cerebral palsy. Urology 128:107–111
doi: 10.1016/j.urology.2019.02.033
Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24):3186–3191
doi: 10.1097/00007632-200012150-00014
Poser CM, Paty DW, Scheinberg L et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3):227–231
doi: 10.1002/ana.410130302
McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127
doi: 10.1002/ana.1032
Keszei AP, Novak M, Streiner DL (2010) Introduction to health measurement scales. J Psychosom Res 68(4):319–323
doi: 10.1016/j.jpsychores.2010.01.006
Triantafyllou N, Triantafillou A, Tsivgoulis G (2009) Validity and reliability of the greek version of the multiple sclerosis international quality-of-life questionnaire. J Clin Neurol 5(4):173–177
doi: 10.3988/jcn.2009.5.4.173
Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16(3):297–334
doi: 10.1007/BF02310555
Nunnally JCIHB (1994) Statistical foundations. Psychometric theory. McGraw-Hill, New York
Aharony SM, Lam O, Corcos J. Evaluation of lower urinary tract symptoms in multiple sclerosis patients: review of the literature and current guidelines. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2017;11(1–2):61–64.
Nortvedt MW, Riise T, Myhr KM, Landtblom AM, Bakke A, Nyland HI (2001) Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis (Houndmills, Basingstoke, England) 7(4):231–235
doi: 10.1177/135245850100700404
Piperidou HN, Heliopoulos IN, Maltezos ES, Milonas IA (2003) Epidemiological data of multiple sclerosis in the province of Evros. Greece Euro Neurol 49(1):8–12
doi: 10.1159/000067020
Cintra LKL, de Bessa JJ, Kawahara VI et al (2019) Cross-cultural adaptation and validation of the neurogenic bladder symptom score questionnaire for Brazilian Portuguese. Int Braz J Urol 45(3):605–614
doi: 10.1590/s1677-5538.ibju.2018.0335
Cronbach LJ, Meehl PE (1955) Construct validity in psychological tests. Psychol Bull 52(4):281–302
doi: 10.1037/h0040957
Terwee CB, Bot SD, de Boer MR et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42
doi: 10.1016/j.jclinepi.2006.03.012